Acutus Medical sale of its left-heart access portfolio products
We are advising Acutus Medical on the transaction
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Ingenovis Health acquisition of VISTA Staffing Solutions
We are advising Ingenovis Health, Cornell Capital and Trilantic on the transaction
Novo Nordisk insulin pricing litigation victory
We prevailed in having the complaint dismissed with prejudice
Signify Health defeats bid for preliminary injunction in trade-secret dispute
We secured a favorable resolution of all claims on behalf of Signify
Olympus $500 million senior notes offering
The debut offering consisted of 2.143% senior notes due 2026
Securities litigation victory for Synergy Pharmaceuticals officers and directors
We secured a total victory for the clients, with all claims against them dismissed
Magnolia Medical Technologies patent litigation against Kurin
We are serving as lead trial counsel for Magnolia Medical in an action against its sole competitor
Signify Health trade-secret case against CareCentrix
We are defending Signify Health against trade-secret-misappropriation and related claims
Coloplast acquisition of Nine Continents Medical
Davis Polk advised Coloplast on its acquisition of Nine Continents Medical, an early stage company pioneering an implantable tibial nerve stimulation treatment for over-active bladder. The…
Gilead Sciences $21 billion acquisition of Immunomedics
Davis Polk is advising Gilead Sciences, Inc. in its acquisition of Immunomedics, Inc. for $88.00 per share in cash. The transaction, which values Immunomedics at approximately $21 billion,…